Clinical Trials Browser

Recurrence × cabazitaxel × Clear all

NCT01952223 2025-07-30

PEACE2

Phase 3 Active not recruiting

Adenocarcinoma, Recurrence

NCT02202772 2025-02-24

CGC

Phase 1/2 Active not recruiting

Carcinoma, Neoplasms, Recurrence

NCT03114254 2022-11-18

JAVA-P

Phase 2 Completed

Neoplasm Metastasis, Penile Neoplasms, Recurrence

NCT01620242 2021-03-02

ORL03

Phase 2 Completed

Head and Neck Neoplasms, Recurrence

NCT02560337 2020-10-08

CaTo-ROC

Phase 2 Completed

Ovarian Neoplasms, Recurrence

NCT02166658 2018-01-23

CaBaMet

Phase 2 Terminated

BreastCNSThoracic

Brain Neoplasms, Breast Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Recurrence

NCT01531205 2014-11-05

Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA

Phase 2 Terminated

2 enrolled 6 charts

Prostatic Neoplasms, Recurrence